Evidence map›Paper›PMID 41141832›Full record

ArticleACS omega2025

Engineering Two-in-One Nanoparticles for Simultaneous Delivery of Graphene Quantum Dot and Pemetrexed.

Umut Can Öz, Berrin Küçüktürkmen, I Jénnifer Gómez, Amr Elsherbeny, Seda Ipek Tekneci, Özgür Eşim, Selin Göksever, Umut Uğur Özköse, Sevgi Gülyüz, Claudia Bazán-Cobelo and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Umut Can ÖzDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara 06560, Türkiye.ORCID https://orcid.org/0000-0001-5225-748X
Berrin KüçüktürkmenDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara 06560, Türkiye.
I Jénnifer GómezCICA-Centro Interdisciplinar de Química e Bioloxía, Universidade da Coruña, Rúa as Carballeiras, A Coruña 15071, Spain.ORCID https://orcid.org/0000-0002-1493-1864
Amr ElsherbenyDivision of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.
Seda Ipek TekneciDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara 06560, Türkiye.
Özgür EşimDepartment of Pharmaceutical Technology, Gulhane Faculty of Pharmacy, University of Health Sciences, Etlik, Keçiören, Ankara 06010, Turkey.
Selin GökseverDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara 06560, Türkiye.
Umut Uğur ÖzköseMarmara Research Center, TUBITAK, Gebze, Kocaeli 41470, Türkiye.
Sevgi GülyüzMarmara Research Center, TUBITAK, Gebze, Kocaeli 41470, Türkiye.
Claudia Bazán-CobeloCICA-Centro Interdisciplinar de Química e Bioloxía, Universidade da Coruña, Rúa as Carballeiras, A Coruña 15071, Spain.ORCID https://orcid.org/0009-0004-3570-3440
Özgür YılmazMarmara Research Center, TUBITAK, Gebze, Kocaeli 41470, Türkiye.
Aylin ÜstündağDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara 06560, Türkiye.ORCID https://orcid.org/0000-0002-8449-1358
Jiřina MedalováDepartment of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno 62500, Czech Republic.
Asuman BozkırDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara 06560, Türkiye.ORCID https://orcid.org/0000-0002-2782-3280
Lenka ZajíčkováDepartment of Condensed Matter Physics, Faculty of Science, Masaryk University, Brno 61137, Czech Republic.ORCID https://orcid.org/0000-0002-6906-8906
Engin ErDepartment of Biotechnology, Biotechnology Institute, Ankara University, Keçiören, Ankara 06135, Türkiye.ORCID https://orcid.org/0000-0002-7713-3704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The simultaneous delivery of therapeutic agents and imaging probes using polymeric nanoparticles (NPs) has gained significant attention for cancer treatment. In this work, we developed a multifunctional nanocarrier system composed of an amphiphilic block copolymer, poly-(2-ethyl-2-oxazoline)-

Identifiers

PMID41141832
PMCPMC12547751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.